ENDRA Life Sciences (NDRA) Gross Profit (2016 - 2018)

ENDRA Life Sciences (NDRA) has reported Gross Profit for 3 consecutive years, with $6174.0 the latest figure, recorded in Q1 2018.

• On a quarterly basis, Gross Profit changed N/A year-over-year to $6174.0 in Q1 2018; TTM through Dec 2018 was $6174.0, a 96.55% decrease from a year earlier, with the FY2018 full-year figure at $6174.0, down 96.55% from the prior year.
• Gross Profit was $6174.0 for Q1 2018 at ENDRA Life Sciences, up from $3765.0 in the prior quarter.
• Over five years, Gross Profit peaked at $279704.0 in Q4 2016 and troughed at $3765.0 in Q4 2017.
• A 3-year average of $92943.6 and a median of $6345.0 in 2017 frame the typical range for Gross Profit.
• The widest YoY moves for Gross Profit: up 98.65% in 2017, down 98.65% in 2017.
• Over 3 years, Gross Profit stood at $279704.0 in 2016, then tumbled by 98.65% to $3765.0 in 2017, then soared by 63.98% to $6174.0 in 2018.
• The last three Gross Profit figures came in at $6174.0 (Q1 2018), $3765.0 (Q4 2017), and $168730.0 (Q3 2017), per Business Quant data.